13F-HR filed by Allworth Financial LP
Allworth Financial LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-05, with 5,001 holding rows worth $24,413,220,393.
- Accession
- 0001140361-26-003753
- Filer
- CIK 1555170
- Filed
- 2026-02-05
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 5,179 entries on the cover page, a total value of $24,413,220,393 stated on the cover page (in dollars after the unit check, H1), rows summing to $24,413,220,393 with VALUE read as dollars as filed, 13F file number 028-15046. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GT BIOPHARMA INC | 36254L308 | COM | 1 | $1 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-26-003753 | this filing | 2026-02-05 | acceptance time not in the bulk data set |